The
goal of the current study was to assess the clinical profile and its
complications that aid in early malaria recognition and prompt treatment,
thereby lowering morbidity and mortality.
One of the most frequent causes of fever and other associated human misery is
still malaria. It continues to be a significant burden for tropical nations
despite ongoing prevention initiatives. Despite being nearly eradicated from
many nations, including the United States, Canada, Europe, and Russia, malaria
has recently presented new challenges in terms of changing clinical profiles
and management, particularly p. vivax infection, which is frequently found to
cause severe malaria and, contrary to popular belief, defies early detection
and timely antimalarial medication.
From the indoor and outdoor sections of the Magadh Medical College Hospital in
Gaya, a total of 96 patients were enrolled. Rapid testing and a peripheral
blood smear examination are used to identify malaria. A comprehensive clinical
examination was conducted, and both regular and specialised lab tests were run.
Current clinical features were also documented. A thorough examination was
done, the right therapy was given, and frequent follow-up was done. Serious
malaria was defined according to WHO standards.
54 percent were infected with vivax, 47 percent with P. falciparum, and 9
percent with mixed illness. More than 30% of individuals exhibited atypical
clinical characteristics, 8.6% showed warning signals, and 31% experienced
severe malaria. In contrast to common belief, P. vivax also experienced
problems.
Early diagnosis is the key to reducing morbidity and death. Typical but
deceptive clinical symptoms include cough, severe headache, severe myalgia,
diarrhoea, stomach pain, severe arthralgia, oliguria, and malena. Unusual
symptoms were seen in a large majority of the individuals in this group.
In India, different regions have different rates of malaria as well as
different ratios of p. vivax and p. falciparum. P. vivax is the dominating
species in the Magadh zone of Bihar. Malaria is still a significant problem for
public health. P vivax's altered clinical profile and increased pathogenicity
have drawn attention. Understanding these traits enables early detection and
improves results.
Author (s) Details:
Pramod Kumar Sinha,
Department of Medicine, Anugrah Narayan Magadh Medical College Hospital , Gaya-823001 (Bihar), India.
S. N. Singh,
Department of Medicine, Anugrah Narayan Medical College Hospital, Gaya, (Bihar), India.
Deo Chaudhary,
Department of Medicine, Anugrah Narayan Medical College Hospital, Gaya, (Bihar), India.
Please see the link here: https://stm.bookpi.org/CODHR-V1/article/view/7430
No comments:
Post a Comment